Javascript must be enabled to continue!
EXPLORING THE CYTOTOXIC POTENTIAL OF HYDROALCOHOLIC EXTRACT FROM OXYSTELMA ESCULENTUM AGAINST HUMAN CANCER CELL LINES
View through CrossRef
Cancer is a leading cause of death worldwide, necessitating the discovery of novel therapeutic agents. Natural products, particularly medicinal plants, are increasingly being explored for their anticancer properties. Oxystelma esculentum, a plant traditionally used in Ayurvedic medicine, is known for its wide range of pharmacological effects. This study investigates the anticancer potential of a hydroalcoholic extract of Oxystelma esculentum against human cancer cell lines.
The aerial parts of Oxystelma esculentum were extracted using a 70% ethanol solution, and cytotoxicity was evaluated using MTT and CellTiter-Glo assays. Cancer cells were treated with the extract at concentrations of 100 mg/mL, 250 mg/mL, and 500 mg/mL for 48 hours. The IC50 values were calculated using non-linear regression analysis. The extract demonstrated dose-dependent cytotoxicity in the cancer cell lines, with IC50 values of approximately 230 mg/mL. Cell viability decreased significantly, with a maximum inhibition of 85% at the highest concentration (500 mg/mL). The extract also showed significant ATP depletion in the CellTiter-Glo assay, indicating reduced cellular metabolism.
The results suggest that the hydroalcoholic extract of Oxystelma esculentum exhibits potent anticancer activity, likely due to its rich content of bioactive compounds such as flavonoids, saponins, and phenolic acids. These findings indicate that Oxystelma esculentum has the potential to be developed into a plant-based anticancer therapy. Further studies are warranted to elucidate the molecular mechanisms involved and to validate the efficacy of the extract in vivo.
Kashf Institute of Development & Studies
Title: EXPLORING THE CYTOTOXIC POTENTIAL OF HYDROALCOHOLIC EXTRACT FROM OXYSTELMA ESCULENTUM AGAINST HUMAN CANCER CELL LINES
Description:
Cancer is a leading cause of death worldwide, necessitating the discovery of novel therapeutic agents.
Natural products, particularly medicinal plants, are increasingly being explored for their anticancer properties.
Oxystelma esculentum, a plant traditionally used in Ayurvedic medicine, is known for its wide range of pharmacological effects.
This study investigates the anticancer potential of a hydroalcoholic extract of Oxystelma esculentum against human cancer cell lines.
The aerial parts of Oxystelma esculentum were extracted using a 70% ethanol solution, and cytotoxicity was evaluated using MTT and CellTiter-Glo assays.
Cancer cells were treated with the extract at concentrations of 100 mg/mL, 250 mg/mL, and 500 mg/mL for 48 hours.
The IC50 values were calculated using non-linear regression analysis.
The extract demonstrated dose-dependent cytotoxicity in the cancer cell lines, with IC50 values of approximately 230 mg/mL.
Cell viability decreased significantly, with a maximum inhibition of 85% at the highest concentration (500 mg/mL).
The extract also showed significant ATP depletion in the CellTiter-Glo assay, indicating reduced cellular metabolism.
The results suggest that the hydroalcoholic extract of Oxystelma esculentum exhibits potent anticancer activity, likely due to its rich content of bioactive compounds such as flavonoids, saponins, and phenolic acids.
These findings indicate that Oxystelma esculentum has the potential to be developed into a plant-based anticancer therapy.
Further studies are warranted to elucidate the molecular mechanisms involved and to validate the efficacy of the extract in vivo.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Allium Sativum as a Novel Therapeutic Agent in the Treatment of Oral Squamous Cell Carcinoma: An In-Vitro Cell Line Study
Allium Sativum as a Novel Therapeutic Agent in the Treatment of Oral Squamous Cell Carcinoma: An In-Vitro Cell Line Study
Introduction:
No significant differences have been observed in the survival index of oral squamous cell carcinoma/oral cancer/OSCC over the past decades with th...
ANTIULCER, ANALGESIC AND HEPATOPROTECTIVE ACTIVITIES OF HYDROALCOHOLIC ROOT EXTRACT OF JURINEA DOLOMIAEA BOISS
ANTIULCER, ANALGESIC AND HEPATOPROTECTIVE ACTIVITIES OF HYDROALCOHOLIC ROOT EXTRACT OF JURINEA DOLOMIAEA BOISS
The herb Jurinea Dolomiaea Boiss, which is a member of the Astraceae family, has long been used in Ayurveda to treat liver diseases and as an anticancer, antioxidant, and anti-diab...
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract
BACKGROUND: Multiple steps and factors are involved in prostate carcinogenesis and tumor progression. The early studies have found that tumor-associated mac...

